Holderness Investments Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.11M | Buy |
34,714
+2,843
| +9% | +$166K | 0.42% | 65 |
|
|
2025
Q4 | $1.72M | Buy |
31,871
+15
| +0% | +$722 | 0.35% | 66 |
|
|
2025
Q3 | $1.44M | Sell |
31,856
-8,222
| -21% | -$384K | 0.29% | 70 |
|
|
2025
Q2 | $1.86M | Sell |
40,078
-2,414
| -6% | -$118K | 0.4% | 62 |
|
|
2025
Q1 | $2.59M | Sell |
42,492
-278
| -0.6% | -$16.2K | 0.6% | 47 |
|
|
2024
Q4 | $2.42M | Buy |
42,770
+2,128
| +5% | +$119K | 0.53% | 47 |
|
|
2024
Q3 | $2.1M | Buy |
40,642
+1,710
| +4% | +$80.2K | 0.46% | 55 |
|
|
2024
Q2 | $1.62M | Sell |
38,932
-5,484
| -12% | -$245K | 0.38% | 66 |
|
|
2024
Q1 | $2.41M | Buy |
44,416
+184
| +0.4% | +$9.37K | 0.59% | 43 |
|
|
2023
Q4 | $2.27M | Buy |
44,232
+18,352
| +71% | +$963K | 0.62% | 43 |
|
|
2023
Q3 | $1.5M | Sell |
25,880
-903
| -3% | -$55.3K | 0.58% | 45 |
|
|
2023
Q2 | $1.71M | Sell |
26,783
-734
| -3% | -$49.2K | 0.63% | 41 |
|
|
2023
Q1 | $1.91M | Buy |
27,517
+1
| +0% | +$71 | 0.76% | 35 |
|
|
2022
Q4 | $1.98M | Sell |
27,516
-15
| -0.1% | -$1.13K | 0.85% | 34 |
|
|
2022
Q3 | $1.96M | Buy |
27,531
+1
| +0% | +$73 | 0.89% | 27 |
|
|
2022
Q2 | $2.12M | Sell |
27,530
-1,300
| -5% | -$99K | 0.88% | 28 |
|
|
2022
Q1 | $2.1M | Buy |
28,830
+185
| +0.6% | +$12.4K | 0.7% | 35 |
|
|
2021
Q4 | $1.79M | Sell |
28,645
-125
| -0.4% | -$7.33K | 0.53% | 45 |
|
|
2021
Q3 | $1.7M | Sell |
28,770
-705
| -2% | -$46.4K | 0.56% | 44 |
|
|
2021
Q2 | $1.97M | Buy |
29,475
+143
| +0.5% | +$9.32K | 0.65% | 42 |
|
|
2021
Q1 | $1.85M | Sell |
29,332
-78
| -0.3% | -$4.85K | 0.67% | 41 |
|
|
2020
Q4 | $1.82M | Sell |
29,410
-3,124
| -10% | -$192K | 0.71% | 38 |
|
|
2020
Q3 | $1.96M | Buy |
32,534
+862
| +3% | +$51.9K | 0.81% | 33 |
|
|
2020
Q2 | $1.86M | Buy |
31,672
+380
| +1% | +$22.7K | 0.83% | 33 |
|
|
2020
Q1 | $1.74M | Sell |
31,292
-319
| -1% | -$19.5K | 0.99% | 29 |
|
|
2019
Q4 | $2.03M | Buy |
31,611
+2,300
| +8% | +$132K | 0.87% | 33 |
|
|
2019
Q3 | $1.49M | Sell |
29,311
-300
| -1% | -$14.1K | 0.69% | 43 |
|
|
2019
Q2 | $1.34M | Buy |
29,611
+3,686
| +14% | +$172K | 0.61% | 44 |
|
|
2019
Q1 | $1.24M | Buy |
25,925
+660
| +3% | +$32.9K | 0.59% | 48 |
|
|
2018
Q4 | $1.31M | Sell |
25,265
-255
| -1% | -$13.7K | 0.72% | 39 |
|
|
2018
Q3 | $1.58M | Sell |
25,520
-170
| -0.7% | -$10.1K | 0.71% | 40 |
|
|
2018
Q2 | $1.42M | Sell |
25,690
-435
| -2% | -$23.5K | 0.69% | 41 |
|
|
2018
Q1 | $1.65M | Sell |
26,125
-2,607
| -9% | -$168K | 0.82% | 30 |
|
|
2017
Q4 | $1.76M | Sell |
28,732
-100
| -0.3% | -$6.25K | 0.87% | 30 |
|
|
2017
Q3 | $1.84M | Sell |
28,832
-124
| -0.4% | -$7.24K | 0.96% | 24 |
|
|
2017
Q2 | $1.61M | Sell |
28,956
-1,062
| -4% | -$57.8K | 0.86% | 32 |
|
|
2017
Q1 | $1.63M | Buy |
30,018
+3,143
| +12% | +$172K | 0.83% | 34 |
|
|
2016
Q4 | $1.57M | Sell |
26,875
-100
| -0.4% | -$5.47K | 1.39% | 26 |
|
|
2016
Q3 | $1.45M | Sell |
26,975
-15
| -0.1% | -$964 | 1.45% | 21 |
|
|
2016
Q2 | $1.99M | Sell |
26,990
-75
| -0.3% | -$5.3K | 2% | 12 |
|
|
2016
Q1 | $1.73M | Sell |
27,065
-120
| -0.4% | -$7.57K | 1.65% | 20 |
|
|
2015
Q4 | $1.87M | Sell |
27,185
-125
| -0.5% | -$8.26K | 1.85% | 15 |
|
|
2015
Q3 | $1.62M | Sell |
27,310
-665
| -2% | -$42.2K | 1.7% | 19 |
|
|
2015
Q2 | $1.86M | Buy |
27,975
+290
| +1% | +$19.1K | 1.9% | 13 |
|
|
2015
Q1 | $1.79M | Sell |
27,685
-440
| -2% | -$27.5K | 1.81% | 15 |
|
|
2014
Q4 | $1.66M | Buy |
+28,125
| New | +$1.59M | 1.7% | 15 |
|
Other funds holding BMY
VCM
VPM
Holderness Investments Company's BMY Position: Q1 2026 in Review
Holderness Investments Company increased its Bristol-Myers Squibb (BMY) stake by 8.9% in Q1 2026, buying an estimated $166K and bringing the position to 34,714 shares worth $2.11M. The position accounts for 0.42% of the portfolio, ranked #65.
Holderness Investments Company first reported a position in BMY in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.59M in Q1 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Holderness Investments Company held 34,714 shares of Bristol-Myers Squibb worth $2.11M as of Q1 2026.
- Holderness Investments Company bought 2,843 Bristol-Myers Squibb shares in Q1 2026, an estimated $166K.
- Bristol-Myers Squibb made up 0.42% of Holderness Investments Company's portfolio in Q1 2026, its #65 holding.
- Holderness Investments Company first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 46 quarters since.
- Holderness Investments Company's Bristol-Myers Squibb position peaked at $2.59M in Q1 2025.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Holderness Investments Company's 13F filing for Q1 2026, filed 12 May 2026.